The proangiogenic capacity of polymorphonuclear neutrophils delineated by microarray technique and by measurement of neovascularization in wounded skin of CD18-deficient mice

Journal of Vascular Research

Volumn 43, Issue 1, 2005, Pages 1-11

  Schruefer, Ruth ^a   Sulyok, Silke ^b   Schymeinsky, Jürgen ^a   Peters, Thorsten ^b   Scharffetter Kochanek, Karin ^b   Walzog, Barbara ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Inflammation mediated angiogenesis; Neovascularization; Polymorphonuclear neutrophils; Wound repair

Indexed keywords

CD18 ANTIGEN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GRANULATION TISSUE; HUMAN; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INJURY; WILD TYPE; WOUND HEALING;

ADULT; ANIMALS; ANTIGENS, CD18; CYCLOOXYGENASE 2; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHILS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SKIN; URINARY PLASMINOGEN ACTIVATOR; WOUND HEALING;

EID: 29244476827     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088975     Document Type: Article

References (61)

1. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M: Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med 1991;173:771-774.
2. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-1049.
3. Bernardini G, Ribatti D, Spinetti G, Morbidelli L, Ziehe M, Santoni A, Capogrossi MC, Napolitano M: Analysis of the role of chemokines in angiogenesis. J Immunol Methods 2003; 273:83-101.
4. Grenier A, Chollet-Martin S, Crestani B, Izumi H, Ishibashi T, Suzuki H, Kuwano M: Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood 2002;99:2997-3004.
5. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993;90:1937-1941.
6. Gaudry M, Brégerie O, Andrieu V, El Benna J, Pocidalo MA, Hakim J: Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 1997;90:4153-4161.
7. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-248.
8. Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, Wood WI, Moore MW: Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 1994;265:682-684.
9. Devalaraja RM, Nanney LB, Qian Q, Du J, Yu Y, Devalaraja MN, Richmond A: Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol 2000;115:234-244.
10. Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A, Strieter RM: The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 2000;165:5269-5277.
11. Armstrong DA, Major JA, Chudyk A, Hamilton TA: Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J Leukoc Biol 2004;75:641-648.
12. Scapini P, Morini M, Tecchio C, Minghelli S, Di Carlo E, Tanghetti E, Albini A, Lowell C, Berton G, Noonan DM, Cassatella MA: CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J Immunol 2004;172:5034-5040.
13. Benelli R, Morini M, Carrozzino F, Ferrari N, Minghelli S, Santi L, Cassatella M, Noonan DM, Albini A: Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation. FASEB J 2002;16:267-269.
14. Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML: Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. Proc Natl Acad Sci USA 1990;87:6758-6761.
15. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, Kuwano M: Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 1997;17:4015-4023.
16. Schruefer R, Lutze N, Schymeinsky J, Walzog B: Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8. Am J Physiol Heart Circ Physiol 2005;288:H1186-H1192.
17. Scharffetter-Kochanek K, Lu H, Norman K, van Nood N, Munoz F, Grabbe S, McArthur M, Lorenzo I, Kaplan S, Ley K, Smith CW, Montgomery CA, Rich S, Beaudet AL: Spontaneous skin ulceration and defective T cell function in CD18 null mice. J Exp Med 1998;188:119-131.
18. Willeke T, Schymeinsky J, Prange P, Zahler S, Walzog B: A role for Syk-kinase in the control of the binding cycle of the beta2 integrins (CD11/CD18) in human polymorphonuclear neutrophils. J Leukoc Biol 2003;74:260-269.
19. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
20. Gasperini S, Calzetti F, Russo MP, De Gironcoli M, Cassatella MA: Regulation of GRO alpha production in human granulocytes. J Inflamm 1995;45:143-151.
21. Grotendorst GR, Smale G, Pencev D: Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J Cell Physiol 1989;140:396-402.
22. Loukinova E, Dong G, Enamorado-Ayalya I, Thomas GR, Chen Z, Schreiber H, Van Waes C: Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene 2000;19:3477-3486.
23. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS: Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-4171.
24. Takada T, Kinkori T, Muramatsu H, Hayakawa A, Torii S, Muramatsu T: Midkine, a retinoic acid-inducible heparin-binding cytokine, is a novel regulator of intracellular calcium in human neutrophils. Biochem Biophys Res Commun 1997;241:756-761.
25. Takada T, Toriyama K, Muramatsu H, Song XJ, Torii S, Muramatsu T: Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J Biochem 1997;122:453-458.
26. Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S, Muramatsu T: Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 2001;167:3463-3469.
27. Choudhuri R, Zhang HT, Donnini S, Ziehe M, Bicknell R: An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res 1997;57:1814-1819.
28. Muramaki M, Miyake H, Hara I, Kamidono S: Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapy. Clin Cancer Res 2003;9:5152-5160.
29. Ikematsu S, Yano A, Aridome K, Kikuchi M, Kumai H, Nagano H, Okamoto K, Oda M, Sakuma S, Aikou T, Muramatsu H, Kadomatsu K, Muramatsu T: Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer 2000;83:701-706.
30. Mecklenburgh KI, Walmsley SR, Cowburn AS, Wiesener M, Reed BJ, Upton PD, Deighton J, Greening AP, Chilvers ER: Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis. Blood 2002;100:3008-3016.
31. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-732.
32. Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, Ali-Seyed M, Lee DF, Bartholomeusz G, Ou-Yang F, Giri DK, Hung MC: Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 2004;6:251-261.
33. Oda N, Abe M, Sato Y: ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol 1999;178:121-132.
34. Dewald B, Bretz U, Baggiolini M: Release of gelatinase from a novel secretory compartment of human neutrophils. J Clin Invest 1982;70:518-525.
35. Derynck R, Akhurst RJ, Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-129.
36. Shapiro SD: Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998;10:602-608.
37. Iwasaka C, Tanaka K, Abe M, Sato Y: Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 1996;169:522-531.
38. Heiple JM, Ossowski L: Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis. J Exp Med 1986;164:826-840.
39. Brandes ME, Mai UE, Ohura K, Wahl SM: Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta. J Immunol 1991;47:1600-1606.
40. Pepper MS: Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997;8:21-43.
41. Goumans MJ, Lebrin F, Valdimarsdottir G: Controlling the angiogenic switch: a balance between two distinct TGF-beta receptor signaling pathways. Trends Cardiovasc Med 2003;13:301-307.
42. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, Alitalo K: Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994;269:6271-6274.
43. Sehgal I, Thompson TC: Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. Mol Biol Cell 1999;10:407-416.
44. Bohnsack JF, Zhou XN: Divalent cation substitution reveals CD18- and very late antigen-dependent pathways that mediate human neutrophil adherence to fibronectin. J Immunol 1992;149:1340-1347.
45. 2+- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature 1995;377:75-79.
46. Muller WA, Weigl SA, Deng X, Phillips DM: PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993;178:449-460.
47. Kreis C, La Fleur M, Menard C, Faquin R, Beaulieu AD: Thrombospondin and fibronectin are synthesized by neutrophils in human inflammatory joint disease and in a rabbit model of in vivo neutrophil activation. J Immunol 1989;143:1961-1968.
48. Iruela-Arispe ML, Luque A, Lee N: Thrombospondin modules and angiogenesis. Int J Biochem Cell Biol 2004;36:1070-1078.
49. Niiro H, Otsuka T, Izuhara K, Yamaoka K, Ohshima K, Tanabe T, Hara S, Nemoto Y, Tanaka Y, Nakashima H, Niho Y: Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 1997;89:1621-1628.
50. Matzner Y, Bar-Ner M, Yahalom J, Ishai-Michaeli R, Fuks Z, Vlodavsky I: Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. J Clin Invest 1985;76:1306-1313.
51. John A, Tuszynski G: The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001;7:14-23.
52. Iniguez MA, Rodriguez A, Volpert OV, Fresno M, Redondo JM: Cyclooxygenase-2: a therapeutic target in angiogenesis. Trends Mol Med 2003;9:73-78.
53. Tasiemski A, Hammad H, Vandenbulcke F, Breton C, Bilfinger TJ, Pestel J, Salzet M: Presence of chromogranin-derived antimicrobial peptides in plasma during coronary artery by-pass surgery and evidence of an immune origin of these peptides. Blood 2002;100:553-559.
54. Kullander K, Klein R: Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol 2002;3:475-486.
55. Ramchandran R, Dhanabal M, Volk R, Waterman MJ, Segal M, Lu H, Knebelmann B, Sukhatme VP: Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Commun 1999;255:735-739.
56. Triebel S, Blaser J, Gote T, Pelz G, Schuren E, Schmitt M, Tschesche H: Evidence for the tissue inhibitor of metalloproteinases-1 (TIMP-1) in human polymorphonuclear leukocytes. Eur J Biochem 1995;231:714-719.
57. Sang QX: Complex role of matrix metalloproteinases in angiogenesis. Cell Res 1998;8:171-177.
58. Liu XH, Kirschenbaum A, Yu K, Yao S, Levine AC: Cycloxygenase-2 suppresses hypoxia-induced apoptosis via a combination of direct and indirect inhibition of p53 activity in a human prostate cancer cell line. J Biol Chem 2005;280:3817-3823.
59. Harada H, Nakagawa K, Saito M, Kohno S, Nagato S, Furukawa K, Kumon Y, Hamada K, Ohnishi T: Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells. Cancer Lett 2003;191:109-119.
60. Walzog B, Scharffetter-Kochanek K, Gaehtgens P: Impairment of neutrophil emigration in CD18-null mice. Am J Physiol 1999;276:G1125-G1130.
61. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.